Breast cancer cells adapt to metabolic stress by increasing ethanolamine phospholipid synthesis and CTP:ethanolaminephosphate cytidylyltransferase-Pcyt2 activity.
Breast cancer cells adapt to metabolic stress by increasing ethanolamine phospholipid synthesis and CTP:ethanolaminephosphate cytidylyltransferase-Pcyt2 activity.
enzyme is composed of two tandem cytidylyltransferase domains. The histidines, especially the first histidine, in the CTP-binding motif HxGH in the N-terminal CT domain are critical for its catalytic activity in vitro, while those in the C-terminal CT domain are not. Overexpression of the wild-type mutants containing amino acid substitutions in the HxGH motif in the C-terminal CT domain suppresses the growth defect of the Saccharomyces cerevisiae mutant of ECT1 in the absence of a phosphatidylethanolamine supply via the decarboxylation of phosphatidylserine, but overexpression of ECT mutants of the N-terminal CT domain does not
the enzyme is important and the main regulatory enzyme in de novo production of phosphatidylethanolamine via the CDP-ethanolamine Kennedy pathway, overview. Pcyt2 gene is a target of liver X receptor
both isoforms are unique cytidylyltransferases, containing two CTP binding HXGH motifs and large repetitive sequences within the N- and C-domains made by gene duplication. Overexpression of Pcyt2 increases the level of CDP-ethanolamine, but phosphatidylethanolamine content remains unchanged since no adequate diacylglacerol is present
serum-deficient MCF-7 cells adapt to stress conditions by increasing synthesis and content of phosphatidylethanolamine and diacylglycerol. The biosynthesis of phosphatidylethanolamine from diacylglycerol and ethanolamine is regulated at the level of formation of CDP-ethanolamine, the metabolic step catalyzed by Pcyt2. The catalytic activity of Pcyt2 is elevated 2-3fold, yet the enzyme remains rate-limiting in serum-deficient cells. The mRNA levels of two splice variants, Pcyt2alpha and Pcyt2beta, are 1.5-3fold higher in deficient cells. Elevated diacylglycerol formation and the increased activity of the rate-regulatory enzyme Pcyt2 are critical modulators of the phosphatidylethanolamine Kennedy pathway, and total phosphatidylethanolamine content in serum-deprived breast cancer cells
the enzyme is important in de novo production of phosphatidylethanolamine, which is the most abundant lipid on the cytoplasmic layer of cellular membranes, with significant roles in cellular processes such as membrane fusion, cell cycle, autophagy, and apoptosis. Transcriptional regulation of Pcyt2, and Pcyt2 expression in the metabolic syndrome and related disorders, overview. Function of Pcyt2 in cancer cell growth, and Pcyt2 expression in lipid-related disorders and cancer, detailed overview. Phosphatidylethanolamine is the precursor of the ethanolamine phosphoglycerol moiety bound to eukaryotic elongation factor 1A, which plays a crucial role in binding aminoacyl-tRNAs during protein synthesis, the upregulation of Pcyt2 expression in methotrexate-resistant HT-29 cells may be important for the production of phosphoethanolamine as a precursor of ethanolamine-phosphoglycerol moiety bound to eEF1A
splice variant Pcyt2beta is specifically phosphorylated at the end of the first cytidylyltransferase domain. Splice variant Pcyt2alpha is phosphorylated within the alpha-specific motif that is spliced out in Pcyt2beta and on two protein kinase C consensus serine residues, Ser215 and Ser223. Single and double mutations of protein kinase C consensus sites reduce Pcyt2alpha phosphorylation, activity, and phosphatidylethanolamine synthesis by 50-90%. The phosphorylation and activity of endogenous Pcyt2 are dramatically increased with phorbol esters and reduced by specific protein kinase C inhibitors. In vitro translated Pcyt2 is phosphorylated by protein kinase Calpha, protein kinase CbetaI, and protein kinase CbetaII. The phosphorylated sites cluster within and flanking the central linker region that connects the two catalytic domains and is a regulatory segment not present in other cytidylyltransferases
Pcyt2, two splicing isozymes Pcyt2alpha and Pcyt2beta, DNA and amino acid sequence and promoter determination and analysis, human Pcyt2, cDNA isolated from glioblastoma cells, is able to restore the synthesis of CDP-ethanolamine as well as the formation of PE in the enzyme-deficient yeast mutant. Transcriptional regulation of Pcyt2, overview
increased Pcyt2 mRNA levels after serum starvation are suppressed by 25-hydroxycholesterol. The suppressive effect of 25-hydroxycholesterol on mRNA transcription is ameliorated by trichostatin A. Anacardic acid, 25-hydroxycholesterol and 24(S)-hydroxycholesterol suppress the transcription by inhibiting H3K27 acetylation in the promoter. 27-Hydroxycholesterol, 22(S)-hydroxycholesterol and 22(R)-hydroxycholesterol suppress the transcription
25-hydroxycholesterol, an endogenous activator of liver X receptor, and the liver X receptor synthetic agonist TO901317 both significantly reduce the biosynthesis of phosphatidylethanolamine via the CDP-ethanolamine Kennedy pathway by inhibiting the promoter function and expression of Pcyt2 in human MCF-7 cells. The enzyme is downregulated in insulin-resistant muscle
liver X receptor, LXR, can modulate and activate promoter activity and transcription of Pcyt2. Pcyt2 is upregulated in methotrexate-resistant HT-29 cells in comparison to a methotrexate-sensitive colon cancer cell line
Breast cancer cells adapt to metabolic stress by increasing ethanolamine phospholipid synthesis and CTP:ethanolaminephosphate cytidylyltransferase-Pcyt2 activity
Tian, S.; Ohtsuka, J.; Wang, S.; Nagata, K.; Tanokura, M.; Ohta, A.; Horiuchi, H.; Fukuda, R.
Human CTP:phosphoethanolamine cytidylyltransferase: enzymatic properties and unequal catalytic roles of CTP-binding motifs in two cytidylyltransferase domains
Side-chain oxysterols suppress the transcription of CTP phosphoethanolamine cytidylyltransferase and 3-hydroxy-3-methylglutaryl-CoA reductase by inhibiting the interaction of p300 and NF-Y, and H3K27 acetylation